This is the second in a series of three posts on the lessons learned from key presentations at the recent ISPOR 2021, specifically as they relate to real-world data (RWD) and real-world evidence (RWE). Our first post focused on the increasing acceptance of RWD and RWE...
This is the first in a series of three posts on the lessons learned from key presentations at the recent ISPOR 2021, specifically as they relate to real-world data and real-world evidence. In December of 2018, the FDA released its Framework for the Real-World Evidence...
Pamela Landsman-Blumberg, MPH, DrPH is Vice President, Value and Access Consulting at TriNetX. She has over 25 years of experience in the pharmaceutical industry. She currently leads Real-World Evidence, Datasets, and Consulting (RW-EDC), a new business unit within...
